The VMs used were panCK, CD3, CD45, and SYTO13 that aid in the selection of no segmented circular ROI (500 microns diameter) per core based on the highest percentage of tumor cells; each ROI was also assessed by tumor cell composition. This evidence concerns the gene PTPRC and neoplasm.